Systemic Corticosteroids Required Only for Moderate-to-Severe Ipilimumab-Induced Hepatitis

被引:0
|
作者
De Felice, Kara M.
Markovic, Svetomir
Kottschade, Lisa A.
Finnes, Heidi D.
Kamath, Patrick S.
Raffals, Laura H.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1312
引用
收藏
页码:S260 / S260
页数:1
相关论文
共 50 条
  • [31] Evaluation of the Efficacy and Safety of Anifrolumab in Moderate-to-Severe Systemic Lupus Erythematosus
    Cingireddy, Ananya Reddy
    Ramini, Navya
    Cingireddy, Anirudh Reddy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [32] French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults
    Amatore, F.
    Villani, A-P
    Tauber, M.
    Guillot, B.
    Viguier, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (6-7): : 429 - 439
  • [33] Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
    Jonathan I. Silverberg
    H. Chih-ho Hong
    Brian M. Calimlim
    Wan-Ju Lee
    Henrique D. Teixeira
    Eric B. Collins
    Marjorie M. Crowell
    Scott J. Johnson
    April W. Armstrong
    Dermatology and Therapy, 2023, 13 : 2247 - 2264
  • [34] Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis
    Silverberg, Jonathan, I
    Hong, H. Chih-ho
    Thyssen, Jacob P.
    Calimlim, Brian M.
    Lee, Wan-Ju
    Teixeira, Henrique D.
    Collins, Eric B.
    Crowell, Marjorie M.
    Johnson, Scott J.
    Armstrong, April W.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [35] Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
    Silverberg, Jonathan, I
    Hong, H. Chih-ho
    Calimlim, Brian M.
    Lee, Wan-Ju
    Teixeira, Henrique D.
    Collins, Eric B.
    Crowell, Marjorie M.
    Johnson, Scott J.
    Armstrong, April W.
    DERMATOLOGY AND THERAPY, 2023, 13 (10) : 2247 - 2264
  • [36] Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Fujimoto, Eita
    Saeki, Hidehisa
    Kanda, Naoko
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3201 - 3212
  • [37] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Okragly, Angela
    Sun, Zhe
    Mena, Laura Rebeca
    Hahn, Nathan
    Nickoloff, Brian J.
    Siu, Kimberly
    Gallo, Gaia
    Wolf, Eric
    Eyerich, Kilian
    Aparici, Monica
    Benschop, Robert J.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II4 - II5
  • [38] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L. R.
    Hahn, N.
    Nickoloff, B. J.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
  • [39] Estimating Prevalence of Moderate-to-Severe Systemic Lupus Erythematosus. A Literature Review
    Lopez Gonzalez, Raquel
    Hinojosa Campos, Marina
    Barnett, Rosie
    Licona, Lyndsi
    Podmore, Belene
    Qizilbash, Nawab
    Schlienger, Raymond
    Seemayer, Christian A.
    Cerani, Agustin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 149 - 150
  • [40] A REAL-WORLD CHARACTERIZATION OF PATIENTS WITH "MODERATE-TO-SEVERE" SYSTEMIC LUPUS ERYTHEMATOSUS
    Strand, V
    Johnson, J.
    Vandeloo, C.
    Galateanu, C.
    Lobosco, S.
    VALUE IN HEALTH, 2014, 17 (07) : A522 - A522